Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
risperidone (risperdal) (1 trial)
val201 (1 trial)
Adenocarcinoma (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)